79387-69-2Relevant articles and documents
IDOXURIDINE AND ITS ANALOGS AS NEUROPROTECTANS FOR THE TREATMENT OF PARKINSONISM
-
Page/Page column 6; 22; 24; 25, (2018/08/26)
The invention relates to compounds that are useful in the treatment of parkinsonism, such as parkinsonism in connection with Parkinson's disease (PD); dementia with Lewy bodies (DLB); multiple system atrophy (MSA); corticobasal degeneration (CBD); or progressive supranuclear palsy (PSP). The said compounds include in particular idoxuridineand analogs thereofas well as their metabolic precursors, such as ropidoxuridine.The invention further relates to method for identifying compounds useful for the treatment of parkinsonism, said methods comprising detecting the capability of compound to increase the amount of GPR37 in cell membranes.The invention further relates to methods for the chemical synthesis of ropidoxuridine.
Evaluation of α-pyrones and pyrimidones as photoaffinity probes for affinity-based protein profiling
Battenberg, Oliver A.,Nodwell, Matthew B.,Sieber, Stephan A.
experimental part, p. 6075 - 6087 (2011/10/09)
α-Pyrones and pyrimidones are common structural motifs in natural products and bioactive compounds. They also display photochemistry that generates high-energy intermediates that may be capable of protein reactivity. A library of pyrones and pyrimidones was synthesized, and their potential to act as photoaffinity probes for nondirected affinity-based protein profiling in several crude cell lysates was evaluated. Further "proof-of-principle" experiments demonstrate that a pyrimidone tag on an appropriate scaffold is equally capable of proteome labeling as a benzophenone.
1-(2-Deoxy-b-D-ribofuranosyl)-5-iodo-2-pyrimidinone antiviral with low host cell toxicity.
-
, (2008/06/13)
-